Evaluation of 11-dehydro-thromboxane B2 as a biomarker of severity and putative therapeutic target in human acute heart failure and cardiogenic shock
Background: The urinary thromboxane A2 metabolite 11-dehydro-thromboxane B2 (U-11dhTXB2) has been associated with cardiovascular morbidity and mortality, but remains scarcely explored in acute heart failure (AHF) and cardiogenic shock (CS). We evaluated U-11dhTXB2 profile in AHF and CS patients, as...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/142033 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/142033 |